Combination Analgesic Development for Enhanced Clinical Efficacy (CADENCE Trial): Study Protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of an Alpha-Lipoic Acid – Pregabalin Combination for the Treatment of Fibromyalgia Pain
Combination Analgesic Development for Enhanced Clinical Efficacy (CADENCE Trial): Study Protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of an Alpha-Lipoic Acid – Pregabalin Combination for the Treatment of Fibromyalgia Pain
Ian Gilron
1
, MSc, MD
;
Dongsheng Tu
2
, PhD
;
Ronald Holden
2
, PhD
;
Tanveer Towheed
2
, MD
;
Elizabeth Vandenkerkhof
2
, DrPH
;
Roumen Milev
2
, MD, PhD
1
Queen's University
,
Department of Anesthesiology and Perioperative Medicine
,
Queen's University
,
Kingston
,
ON
,
CA
2
Division of Cancer Care and Epidemiology
,
Queen's Cancer Research Institute
,
Kingston
,
ON
,
CA
Corresponding Author:
-
Ian Gilron, MSc, MD
-
Queen's University
-
Department of Anesthesiology and Perioperative Medicine
-
Queen's University
-
Kingston General Hospital
-
76 Stuart Street, Victory 2 Pavillion
-
Kingston, ON
-
CA
-
Phone:
1 613 549 6666 ext 3963
-
Email: gilroni@queensu.ca